SILENCE THERAPEUTICS PLC
Ownership & governance
Executives 5Directors 5Avg age 62Avg tenure 4.2y
IR
Iain Ross
Chief Executive Officer
Age 72Since 2025-12-13Profile →
+9
Executives5
IR
Iain Ross→
Chief Executive Officer
Age 72Since 2025-12-13
RH
Rhonda Hellums→
Director of Finance/CFO
Age 54Since 2022-02-20
CR
Curtis Rambaran
Chief Tech/Sci/R&D Officer
—Since 2020-12-31
JG
J.P. Gabriel
Chief Tech/Sci/R&D Officer
—Since 2022-10-31
SR
Steven Romano→
Chief Tech/Sci/R&D Officer
Age 66Since 2023-03-31
Board of directors5
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| TCG Crossover Management LLC | 6.422 % | 3,033,560 |
| TCG Crossover Management LLC | 6.422 % | 3,033,560 |
| The Invus Group LLC | 6.164 % | 2,911,438 |
| The Invus Group LLC | 6.164 % | 2,911,438 |
| Redmile Group LLC | 4.583 % | 2,164,777 |
Catalog · 2026-07-09
Proxy officers11
| Name | Role | Since | Shares |
|---|---|---|---|
| Iain Ross | Chairman | 2019-11-30 | - |
| Dave Lemus | Director or executive officer | 2018-06-01 | 186,858 |
| David Lemus | Director/Board Member | 2018-06-20 | - |
| James Ede-Golightly | Director/Board Member | 2019-04-24 | - |
| James Ede-Golightly | Director or executive officer | 2025-12-01 | 187,833 |
| Rhonda Hellums | Director/Board Member | 2025-12-17 | - |
| Steven Romano, M.D | Director or executive officer | — | 851,784 |
| Tim McInerney | Director or executive officer | 2025-05-01 | 45,999 |
Proxy · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 33Range 10–75Analysts 6
10Mean 3375
- Strong buy 1
- Buy 5
- Sell 1
Broker actions40 of 60
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Overweight | 32 | 2026-08-11 |
| Cantor Fitzgerald | Initiated | Overweight | — | 2026-06-24 |
| HC Wainwright & Co. | Reiterated | Buy | 75 | 2026-06-17 |
| HC Wainwright & Co. | Reiterated | Buy | 75 | 2026-03-13 |
| HC Wainwright & Co. | Reiterated | Buy | 75 | 2025-09-16 |
| Chardan Capital | Maintained | Buy | 35 | 2025-08-08 |
| HC Wainwright & Co. | Reiterated | Buy | 75 | 2025-06-13 |
| Chardan Capital | Maintained | Buy | 35 | 2025-06-13 |
| Goldman Sachs | Maintained | Sell | 3 | 2025-05-09 |
| Morgan Stanley | Maintained | Overweight | 25 | 2025-05-09 |
| Chardan Capital | Maintained | Buy | 35 | 2025-05-09 |
| HC Wainwright & Co. | Reiterated | Buy | 75 | 2025-03-07 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.